BioPharma Credit plc (BPCR) ORD USD0.01
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
n/a
n/a
$0.94
99.06
$0.85
n/a
$0.83
-13.99%
$0.00 (0.23%) Previous:
$0.00
n/a
8.24%
USD
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 3.19% | 1 year 1Y | 4.06% |
|---|---|---|---|
| 1 month 1M | 3.85% | 2 years 2Y | 11.09% |
| 3 months 3M | 5.97% | 3 years 3Y | 12.19% |
| 6 months 6M | 0.95% | 5 years 5Y | 16.67% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | No benchmark |
|---|---|
| Annual management charge: | 1% of Net Assets |
| Performance fee: | Yes |
| Ongoing charge: | 1.14% |
| Dividend yield: | 8.24% |
| Dividend frequency: | Quarterly |
| Total assets: | £1,178m |
| Gross gearing: | 0% |
| Market capitalisation:Market cap.: | £1,013m |
| Shares in issue: | 1.19 bn |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB00BDGKMY29 |
Recent dividends paid or declared by BioPharma Credit plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| 3rd interim | 26/09/2024 | 29/10/2024 | 1.75¢ |
| Special | 26/09/2024 | 29/10/2024 | 2.04p |
| 2nd interim | 04/07/2024 | 31/07/2024 | 1.75¢ |
| 1st interim | 28/03/2024 | 30/04/2024 | 1.75¢ |
| Special | 15/02/2024 | 15/03/2024 | 1.2079¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual BioPharma Credit plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2023 | 8.30% | 1.44 | $0.07 |
| 31/12/2022 | 7.40% | 1.85 | $0.1 |
| 31/12/2021 | 7.20% | 1.13 | $0.07 |
| 31/12/2020 | 7.00% | 0.83 | $0.07 |
| 31/12/2019 | 6.90% | 1.18 | $0.07 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | $99.06 |
|---|---|
| Latest actual NAV: | $78.67 |
| Latest actual NAV date: | 30 November 2024 |
| Premium/Discount: | -13.99% |
| 12m average Premium/Discount: | -11.01% |
| NAV frequency: | Monthly |
| Security | Weight |
|---|---|
| Collegium | 18.98% |
| Lumira Dx | 11.34% |
| Insmed Inc | 11.00% |
| Coherus | 9.41% |
| BioCryst Pharmaceuticals Inc | 9.15% |
| Bms | 6.75% |
| OptiNose Inc | 5.38% |
| Evolus | 3.77% |
| Urogen | 3.77% |
| Immunogen Inc | 2.82% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United States | 28.36% |
Key Dates
| Launch date: | 22 March 2017 |
|---|---|
| Financial year end: | December |
| Next AGM: | May 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.